Abstract:The mechanisms of Parkinson’s disease consist of insufficient neuronal dopaminergic activity in midbrain areas. This has to do with accelerated loss of dopaminergic neurons, or dampened synthesis and release of dopamine, or dysfunction of dopamine receptors. The disease is relatively easy to diagnose owing to well recognized classical symptoms. The symptoms are of motor and non-motor character. The former consist of tremors, disorders of gait and balance, frequent falls, and most notably muscle rigidity and stiffness that cause a characteristic flexed walking posture. The latter consist of sensory and cognitive deficits. So far little attention has been paid to respiratory disorders. These disorders may be counted as belonging to yet another category – premotor disorders, since they are concerned with changes in premotor neurons setting central respiratory activity running down to spinal motor neurons moving the diaphragm. There are two possible reasons of respiratory changes in parkinsonism: stiffness of the chest, mechanically obstructing respiratory movements, and the lack of dopamine which is influential in facilitating respiration at the central level, albeit the issue of the dopamine role in respiration is complex and contentious. Impaired lung ventilation causes hypoxemia, which is the cause of further deterioration of bodily functions. Recognition of ventilatory changes in parkinsonism is, therefore, of practical therapeutic importance. In this study we set out to examine lung ventilation in an experimental model of parkinsonism induced by reserpine plus alpha-methyltyrosine in rats. Ventilation was recorded in a rodent plethysmograph in conscious unrestrained animals. We found that resting ventilation and the stimulatory ventilatory responses to hypoxia (8% O2 in N2) were significantly depressed in parkinsonic rats, as compared with healthy untreated ones. The findings, in all likelihood, reflect the missing stimulatory influence of central dopamine on ventilation, which underlines the development of parkinsonic symptoms.The study points attention to the possibility of ventilatory depression as a sequel of parkinsonism. The corollary is that breathing exercise, by improving lung ventilation and in consequence delivery of oxygen to the arterial blood, could be of value in enhancing the effects of other treatment modalities. Breathing exercise could also enhance cognitive abilities, particularly in older age.Breathing exercise should become part of the comprehensive physical rehabilitation program for elderly patients. Such a program, consisting of exercise, proper nutrition, social activity, home oxygen therapy, and psychosocial support has been developed in Japan (Comprehensive Pulmonary Rehabilitation: Manual for Team Approach. Edited by K. Kida. Medical Review Co. Tokyo, Japan, 1995). The program is now advocated also in patients suffering from neurodegenerative brain conditions, including Parkinson’s disease. Particularly, home oxygen therapy, combined with breathing exercises, is noteworthy, as it holds an obviously greater potential to improve tissue oxygenation, exercise capacity, and patients’ quality of life.

Stimulation of retrotrapezoid nucleus Phox2b‐expressing neurons rescues breathing dysfunction in an experimental Parkinson’s disease rat model

Oxidative Stress Inhibition Via Apocynin Prevents Medullary Respiratory Neurodegeneration and Respiratory Pattern Dysfunction in a 6-Hydroxydopamine Animal Model of Parkinson's Disease

Respiratory disturbances in a mouse model of Parkinson's disease

Regulation of blood vessels by ATP in the ventral medullary surface in a rat model of Parkinson's disease

State-dependent alteration of respiration in a rat model of Parkinson's disease

Novel role for non-invasive neuromodulation techniques in central respiratory dysfunction

Impact of Serotonergic 5HT1A and 5HT2A Receptor Activation on the Respiratory Response to Hypercapnia in a Rat Model of Parkinson's Disease

Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease

Vagus nerve stimulation with a small total charge transfer improves motor behavior and reduces neuroinflammation in a mouse model of Parkinson's disease

Right Vagus Nerve Stimulation Improves Motor Behavior by Exerting Neuroprotective Effects in Parkinson's Disease Rats

Pre-sympathetic C1 RVLM neurons drives sleep disordered breathing in heart failure through activation of central chemoreceptors

Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia

Absence of a synergic nigral proapoptotic effect triggered by REM sleep deprivation in the rotenone model of Parkinson´s disease

Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson's disease

Dopamine D2 receptor activation counteracts olfactory dysfunction and related cellular abnormalities in experimental parkinsonism

Breathing and its rehabilitation in Parkinson's disease

Stimulation of the Medial SNr Promotes Sustained Motor Recovery and Counteracts Parkinsonian Pathophysiology in Dopamine Depleted Mice

Optogenetic stimulation of the pre‐Bötzinger Complex and the control of breathing in a mouse model of Parkinson's disease

Auricular Vagus Nerve Stimulation Exerts Antiinflammatory Effects and Immune Regulatory Function in a 6-OHDA Model of Parkinson’s Disease

Brainstem Modulates Parkinsonism-Induced Orofacial Sensorimotor Dysfunctions

Knockdown of PHOX2B in the retrotrapezoid nucleus reduces the central CO chemoreflex in rats